Research graph

Cited by

Admitted local publications that cite Fosfomycin as Oral Transition Therapy Versus Continued Intravenous β-Lactams for Complicated Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase–Producing Enterobacterales : A Multicenter, Open-Label, Randomized Controlled Trial.